Neoadjuvant radiotherapy combined with targeted and immune therapies achieves a pathological complete response in borderline resectable gallbladder cancer: a case report and literature review
This case underscores the potential of integrating radiotherapy with targeted therapies and ICIs as a translational treatment approach capable of facilitating successful R0 resection in patients with critically resectable gallbladder cancer, with the added benefit of achieving complete pathological remission.
Authors
- Ying Zhao (ORCID: https://orcid.org/0000-0002-1098-2832)
- Tao Li (ORCID: https://orcid.org/0000-0002-9643-5185)
- Zhiqin Li (ORCID: https://orcid.org/0000-0002-2903-1375)
- Guangxin Li (ORCID: https://orcid.org/0000-0003-4754-6046)
- Keren Li (ORCID: https://orcid.org/0000-0001-6253-9747)
- Li Gong
Institutions
- Beijing Tsinghua Chang Gung Hospital (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.3389/fonc.2025.1574329
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Natural Science Foundation of Fujian Province